Related Experiment Video
Updated: Feb 13, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC
Peng Hao1, Bo Kang2, Guoqing Yao3
1Department of Urology, First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang 154003, P.R. China.
Abstract:
Dysregulation of microRNAs (miRNAs/miRs) is frequently associated with cancer progression. Altered expression of miR-211 has been observed in various types of human cancer; however, its expression and role in prostate cancer (PCa) remains unknown. In the present study, the expression of miR-211 in PCa cell lines and tissues was measured by reverse transcription-quantitative PCR (qPCR), revealing that miR-211 was downregulated in PCa cell lines and tissues. Further analysis revealed that low miR-211 was associated with the tumor stage and Gleason score. With the assistance of miR-211 mimics and inhibitor, it was also revealed that the overexpression of miR-211 could inhibit PCa cell proliferation in vitro. Conversely, downregulated miR-211 expression promotes PCa cell proliferation. In addition, the secreted protein acidic and rich in cysteine (SPARC) was identified as a target of miR-211 in the PCa cell lines, and SPARC expression was inversely associated with miR-211. In conclusion, it was demonstrated that the miR-211 expression was downregulated in PCa cell lines and tissues. Additionally, miR-211 could inhibit PCa cell proliferation partially by downregulating SPARC. Therefore, miR-211 may be a potential therapeutic target for PCa treatment in the future.
Insights
MicroRNA-211 (miR-211) is downregulated in prostate cancer (PCa), inhibiting tumor cell proliferation. Restoring miR-211 levels may offer a new therapeutic strategy for PCa treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA (miRNA) dysregulation is linked to cancer progression.
- The role of miR-211 in prostate cancer (PCa) is currently unknown.
Purpose of the Study:
- To investigate the expression and function of miR-211 in prostate cancer.
- To identify potential therapeutic targets for PCa.
Main Methods:
- Reverse transcription-quantitative PCR (qPCR) to measure miR-211 expression.
- In vitro experiments using miR-211 mimics and inhibitors to assess cell proliferation.
- Identification of miR-211 targets using PCa cell lines.
Main Results:
- miR-211 expression was significantly downregulated in PCa cell lines and tissues.
- Low miR-211 levels correlated with advanced tumor stage and higher Gleason scores.
- Overexpression of miR-211 inhibited PCa cell proliferation, while its downregulation promoted it.
- Secreted protein acidic and rich in cysteine (SPARC) was identified as a direct target of miR-211, with inverse expression correlation.
Conclusions:
- miR-211 is downregulated in prostate cancer.
- miR-211 inhibits PCa cell proliferation, partly through the downregulation of SPARC.
- miR-211 represents a potential therapeutic target for prostate cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Cells Coordinate Growth and Proliferation
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...

